Jeff Groth

721 total citations
10 papers, 462 citations indexed

About

Jeff Groth is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jeff Groth has authored 10 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Jeff Groth's work include Prostate Cancer Treatment and Research (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Jeff Groth is often cited by papers focused on Prostate Cancer Treatment and Research (3 papers), RNA modifications and cancer (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Jeff Groth collaborates with scholars based in United States, China and Switzerland. Jeff Groth's co-authors include Joseph Geradts, Huayi Huang, Lesleyann Hawthorn, Stephanie Beall, Khalid Sossey‐Alaoui, Jiaoti Huang, Xufeng Chen, Hailiang Hu, Chang Yin Liang and Lingfan Xu and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jeff Groth

10 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeff Groth United States 9 198 186 165 155 61 10 462
C. A. Martindale United Kingdom 11 163 0.8× 234 1.3× 147 0.9× 155 1.0× 37 0.6× 15 531
Jimmy Pramana Netherlands 5 171 0.9× 178 1.0× 178 1.1× 145 0.9× 50 0.8× 7 458
Daniel E. Soto United States 12 136 0.7× 193 1.0× 169 1.0× 203 1.3× 64 1.0× 26 574
Cyrus Amir United States 11 221 1.1× 197 1.1× 254 1.5× 184 1.2× 105 1.7× 14 652
Go Oshima United States 7 146 0.7× 113 0.6× 181 1.1× 174 1.1× 35 0.6× 13 418
Janet Taylor United Kingdom 7 304 1.5× 259 1.4× 100 0.6× 125 0.8× 15 0.2× 10 505
Turi Danielsen Norway 10 174 0.9× 160 0.9× 109 0.7× 40 0.3× 58 1.0× 11 367
Walter M. Sahijdak United States 11 164 0.8× 106 0.6× 106 0.6× 168 1.1× 152 2.5× 17 491
Danielle Gioioso United States 8 108 0.5× 148 0.8× 124 0.8× 119 0.8× 57 0.9× 13 440
Kazutoshi Ota Japan 12 116 0.6× 219 1.2× 288 1.7× 61 0.4× 14 0.2× 17 622

Countries citing papers authored by Jeff Groth

Since Specialization
Citations

This map shows the geographic impact of Jeff Groth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Groth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Groth more than expected).

Fields of papers citing papers by Jeff Groth

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff Groth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Groth. The network helps show where Jeff Groth may publish in the future.

Co-authorship network of co-authors of Jeff Groth

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff Groth. A scholar is included among the top collaborators of Jeff Groth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff Groth. Jeff Groth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Chen, Zhong, William Hankey, Yue Zhao, et al.. (2021). Transcription recycling assays identify PAF1 as a driver for RNA Pol II recycling. Nature Communications. 12(1). 6318–6318. 8 indexed citations
2.
Xu, Lingfan, Yu Yin, Yanjing Li, et al.. (2020). A Glutaminase Isoform Switch Drives Therapeutic Resistance and Disease Progression of Prostate Cancer. SSRN Electronic Journal. 1 indexed citations
3.
Yin, Yu, Lingfan Xu, Yan Chang, et al.. (2019). N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway. Molecular Cancer. 18(1). 107–107. 87 indexed citations
4.
Xu, Lingfan, Tao Zeng, Xufeng Chen, et al.. (2018). ATM deficiency promotes progression of CRPC by enhancing Warburg effect. Endocrine Related Cancer. 26(1). 59–71. 23 indexed citations
5.
Horton, Janet K., Rachel Blitzblau, Sua Yoo, et al.. (2015). Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers. International Journal of Radiation Oncology*Biology*Physics. 92(4). 846–855. 101 indexed citations
6.
Horton, Janet K., Sharareh Siamakpour‐Reihani, Chen-Ting Lee, et al.. (2015). FAS Death Receptor: A Breast Cancer Subtype-Specific Radiation Response Biomarker and Potential Therapeutic Target. Radiation Research. 184(5). 456–456. 26 indexed citations
7.
Agrawal, Shefali, Boris W. Kuvshinoff, Thaer Khoury, et al.. (2007). CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma. Journal of Gastrointestinal Surgery. 11(4). 445–451. 40 indexed citations
8.
Sood, Ashwani, Jeff Groth, Mohamed Mokhtar Desouki, et al.. (2007). Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression. Human Pathology. 38(11). 1628–1638. 51 indexed citations
9.
Mhawech‐Fauceglia, Paulette, François R. Herrmann, Wiam Bshara, et al.. (2006). Friend leukaemia integration-1 expression in malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. Journal of Clinical Pathology. 60(6). 694–700. 51 indexed citations
10.
Huang, Huayi, Jeff Groth, Khalid Sossey‐Alaoui, et al.. (2005). Aberrant Expression of Novel and Previously Described Cell Membrane Markers in Human Breast Cancer Cell Lines and Tumors. Clinical Cancer Research. 11(12). 4357–4364. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026